期刊文献+

慢性丙型肝炎患者血清可溶性血管黏附蛋白-1的水平及意义 被引量:2

下载PDF
导出
摘要 目的检测慢性丙型肝炎患者血清可溶性血管黏附蛋白-1(sVAP-1)的水平,分析血清sVAP-1与肝功能各项参数及血清HCV-RNA载量的关系,探讨sVAP-1在慢性丙型肝炎发病中的作用。方法纳入慢性丙型肝炎患者58例及体检健康者30例,ELISA检测观察对象血清sVAP-1的水平;全生化仪检测肝功能,实时荧光定量PCR检测血清HCV-RNA水平。结果慢性丙型肝炎患者与健康对照者血清sVAP-1水平分别为(154.24±45.88)和(72.23±35.82)ng/mL(t=8.53,P<0.05);丙氨酸氨基转移酶(ALT)升高的慢性丙型肝炎患者血清sVAP-1水平高于ALT正常的慢性丙型肝炎患者(t=4.53,P<0.05),且血清sVAP-1与ALT、天冬氨酸氨基转移酶水平呈正相关(r=0.739,r=0.732,均P<0.01),与白蛋白水平呈负相关(r=-0.491,P<0.05),与血清HCV-RNA载量无关(P>0.05)。结论慢性丙型肝炎患者血清sVAP-1水平较正常人高,可能参与了慢性丙型肝炎的发病,其水平与肝细胞炎性损伤程度密切相关。
出处 《广东医学》 CAS CSCD 北大核心 2014年第5期689-690,共2页 Guangdong Medical Journal
基金 新疆生产建设兵团重点领域科技攻关项目(编号:2011BA054)
  • 相关文献

参考文献10

  • 1刘敏,王群兴,杨东亮.肝细胞表达的免疫相关分子与肝脏疾病[J].免疫学杂志,2013,29(1):78-81. 被引量:2
  • 2SALMI M, JALKANEN S. VAP - 1 : an adhesin and an enzyme [J]. Trends Immunology, 2001, 22(4): 211 -216. 被引量:1
  • 3丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 4LALOR P F, SUN P J, WESTON C J, et al. Activation of vascu- lar adhesion protien - 1 on liver endothelium results in an NF - kaapaB- depengdent increase in lymphocyte adhesion[J]. Hepa- tology, 2007, 45 (2) : 465 - 474. 被引量:1
  • 5KURKIJARVI R, YEQUTKIN G G, GUNSON B K, et al. Circu- lating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease [ J ]. Gastroenterology, 2000, 119 (4) : 1096 - 1103. 被引量:1
  • 6SALMI M, YEQUTKIN G G, LEHVONEN R, et al. A cell sur- face amine oxidase directly controls lymphocyte migration[ J]. hn- munity, 2001, 14(3): 265-276. 被引量:1
  • 7马轶.慢性丙型肝炎患者血清生化指标和肝组织病理的相关性分析[J].中国当代医药,2009,16(12):156-156. 被引量:3
  • 8LABOR P F, TUNCER C, WESTON C, et al. Vascular adhesion protein- 1 as a potential therapeutic target in liver disease[J]. Ann N Y Acad Sci, 2007, 1110:485 -496. 被引量:1
  • 9NOONAN T, LUKAS S, PEET G W, et al. The oxidase activity of vascular adhesion protein - I ( VAP - 1 ) is essential for function [J]. Am J Clin Exp Immunol, 2013, 2(2) : 172 - 185. 被引量:1
  • 10MA Q, MANAENKO A, KHATIBI N H, et al. Vascular adhesion protein- 1 irhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice [ J]. J Cereb Blood Flow Metab, 2011, 31(3) : 881 -893. 被引量:1

二级参考文献22

  • 1Xunwang,Zheng-HongYuan,Ling-JieZheng,FengYu,WeiXiong,Jiang-XiaLiu,Gen-XiHu,YaoLi.Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-α[J].World Journal of Gastroenterology,2004,10(12):1740-1745. 被引量:6
  • 2Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869. 被引量:1
  • 3Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698. 被引量:1
  • 4Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155. 被引量:1
  • 5Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18. 被引量:1
  • 6Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137. 被引量:1
  • 7Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12. 被引量:1
  • 8Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144. 被引量:1
  • 9Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214. 被引量:1
  • 10Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081. 被引量:1

共引文献737

同被引文献18

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部